RTW Biotech Opportunities (LSE:RTW) EBITDA


LSE:RTW RTW Biotech Opportunities Ltd LSE:RTW
36 GF Score
Price $2.30
! 2 Warning Signs
View Full Analysis

What is RTW Biotech Opportunities EBITDA?

EBITDA does not apply to banks.

LSE:RTW
36GF Score
RTW Biotech Opportunities Ltd LSE:RTW
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RTW Biotech Opportunities Business Description

Address St Julian’s Avenue, 1st Floor, Royal Chambers, St Peter Port, GGY, GY1 3JX
RTW Biotech Opportunities Ltd is a life sciences and investment fund focused on identifying transformative assets with high growth potential across the biopharma and medtech sectors. It is powering medical breakthroughs that have the potential to transform the wellbeing of people around the world. Its portfolio includes Neurology, Oncology, Inflammation, Cardiovascular, Metabolic, Pulmonary, Ophthalmology, Rare Disease, and Other. Geographically it operates in USA & Canada, the Rest of World, and UK & EU, with the majority of the revenue deriving from USA & Canada.
36GF Score

Get the complete analysis for LSE:RTW

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.30
Price